Oxford Immune Algorithmics (OIA) is a groundbreaking AI company that specializes in immune monitoring and personalized healthcare solutions. Established in 2018 by the University of Oxford, OIA utilizes advanced AI technology to revolutionize disease prevention and eradication. With its innovative approach, the company aims to tailor healthcare strategies to individual immune profiles, ultimately mitigating preventable diseases on a global scale. OIA's commitment to leveraging cutting-edge technology for the betterment of public health positions it as a top contender in the AI and healthcare industries.
There is no investment information